相似文献
1
Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis.
Ann Rheum Dis. 2003 Apr;62(4):368-9. doi: 10.1136/ard.62.4.368.
2
Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease.
Gut. 2006 May;55(5):744-5. doi: 10.1136/gut.2005.087577.
3
Use of biologics in inflammatory bowel disease patients with cirrhosis.
Inflamm Bowel Dis. 2011 Feb;17(2):E15-6. doi: 10.1002/ibd.21434.
4
Treatment of the extraintestinal manifestations of inflammatory bowel disease.
Curr Gastroenterol Rep. 2002 Dec;4(6):513-6. doi: 10.1007/s11894-002-0028-9.
5
Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
J Gastrointestin Liver Dis. 2013 Sep;22(3):333-6.
6
The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
Gastrointest Endosc Clin N Am. 2019 Jul;29(3):405-419. doi: 10.1016/j.giec.2019.03.001. Epub 2019 Apr 12.
7
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
Ophthalmology. 2014 Mar;121(3):785-96.e3. doi: 10.1016/j.ophtha.2013.09.048. Epub 2013 Dec 17.
8
Renal amyloidosis associated with extracapillary glomerulonephritis and vasculitis in a patient with inflammatory bowel disease treated with infliximab.
Clin Nephrol. 2008 Sep;70(3):240-4. doi: 10.5414/cnp70240.
9
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?
Gut. 2009 Dec;58(12):1703. doi: 10.1136/gut.2008.176461.
10
[Perspectives in inflammatory bowel diseases treatment].
Pol Merkur Lekarski. 2009 May;26(155):556-8.
引用本文的文献
1
Withaferin A and Celastrol Overwhelm Proteostasis.
Int J Mol Sci. 2023 Dec 27;25(1):367. doi: 10.3390/ijms25010367.
2
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.
Kidney Int. 2015 Oct;88(4):722-33. doi: 10.1038/ki.2015.162. Epub 2015 Jun 10.
3
Management of cutaneous disorders related to inflammatory bowel disease.
Ann Gastroenterol. 2012;25(1):21-26.
4
A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with Infliximab.
Rheumatol Int. 2008 Sep;28(11):1155-9. doi: 10.1007/s00296-008-0590-z. Epub 2008 May 22.
5
Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome.
Pediatr Nephrol. 2004 Nov;19(11):1281-4. doi: 10.1007/s00467-004-1573-2. Epub 2004 Aug 25.
Zotero 插件